lobbying_activities: 1235881

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1235881	487e89f2-9199-44ed-a22a-54e1a27b1eff	Q1	THE DUBERSTEIN GROUP INC.	12675	PFIZER INC.	2012	first_quarter	PHA	Addressing drug shortages, including enhanced evaluation of companies and manufacturing sites, real-cause analysis, inventory at companies, improving quality control processes - Proposed legislation re these issues. Opiate abuse issues - Proposed legislation re this issue. Tracking and tracing medicines - Proposed legislation re this issue. Antidote for exposure to chemical agents - Executive Branch action re this issue.	HOUSE OF REPRESENTATIVES,SENATE	100000		0	0	2012-04-19T11:25:22.897000-04:00